ANI Neurology, PLLC, dba Alzheimer's Memory Center

Charlotte, North Carolina 28270

0 studies enrolling now · 9 studies all time

What they study most

Agitation and Aggression in Alzheimer's Disease, Agitation in Participants With Dementia of the Alzheimer's Type, Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer Disease, Alzheimer's Disease, Early Alzheimer's Disease

Studies at this site

• A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease — Running, not enrolling
• Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Stopped early
• GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease — Completed
• Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Participants With Dementia of the Alzheimer's Type — Completed
• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• BI 425809 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed
• A Study of Pimavanserin for the Treatment of Agitation and Aggression in Subjects With Alzheimer's Disease — Completed
• Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo — Completed
• BI 409306 in Patients With Cognitive Impairment Due to Alzheimer's Disease. — Completed